-transparent.png){kind=logo}
The pharmacokinetics of orally administered propranolol in doses of 10, 40, 80 and 160 mg was studied in eight healthy volunteers in a cross-over trial. The analytical method applied made possible a parallel determination of propranolol and of 4-OH propranolol. The dose-dependent kinetics of orally administered propranolol was demonstrated. In our study linear dependence could be established only within a dosage range of 40 mg to 160 mg. Both substances determined in plasma, propranolol as well as 4-OH propranolol, show a tendency toward non-linearity, particularly at the lower dosage range between 10 and 40 mg.
Related Publications
Z Kopitar, and
B Vrhova, and
A Lenardic, and
P Cvelbar, and
M Zorz, and
I Francetić
July 1994,
Journal of pharmaceutical sciences,
Z Kopitar, and
B Vrhova, and
A Lenardic, and
P Cvelbar, and
M Zorz, and
I Francetić
June 1988,
International journal of clinical pharmacology, therapy, and toxicology,
Z Kopitar, and
B Vrhova, and
A Lenardic, and
P Cvelbar, and
M Zorz, and
I Francetić
April 1978,
Journal of pharmacokinetics and biopharmaceutics,
Z Kopitar, and
B Vrhova, and
A Lenardic, and
P Cvelbar, and
M Zorz, and
I Francetić
January 1989,
Biopharmaceutics & drug disposition,
Z Kopitar, and
B Vrhova, and
A Lenardic, and
P Cvelbar, and
M Zorz, and
I Francetić
January 1983,
Journal of cardiovascular pharmacology,
Z Kopitar, and
B Vrhova, and
A Lenardic, and
P Cvelbar, and
M Zorz, and
I Francetić
January 1981,
Lancet (London, England),
Z Kopitar, and
B Vrhova, and
A Lenardic, and
P Cvelbar, and
M Zorz, and
I Francetić
January 1980,
Biopharmaceutics & drug disposition,
Z Kopitar, and
B Vrhova, and
A Lenardic, and
P Cvelbar, and
M Zorz, and
I Francetić
July 1984,
The Journal of pharmacology and experimental therapeutics,
Z Kopitar, and
B Vrhova, and
A Lenardic, and
P Cvelbar, and
M Zorz, and
I Francetić
January 1981,
Biopharmaceutics & drug disposition,
Z Kopitar, and
B Vrhova, and
A Lenardic, and
P Cvelbar, and
M Zorz, and
I Francetić
January 1981,
Biopharmaceutics & drug disposition,
